Skip to main content
Equibles

VIMTALABS · Vimta Labs Limited · Documents

Use VIMTALABS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VIMTALABS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
499.10 INR -6.30 (-1.25%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 2341 Avg daily vol (3M) 11.24K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 30, 2026
2026
Oct 30
Earnings call
Q2 FY '27 total income rises 9.9%, EBITDA margin reaches 35.5%

Vimta Labs Limited reported Q2 FY '27 total income of INR1,149 million, up 9.9% year-on-year, EBITDA of INR408 million and a 35.5% margin. Biologics began generating revenue, while CRADS and clinical research are expected to improve in Q3 and Q4.

5 source passages
Total income for Q2 FY '27 stood at INR1,149 million as compared to INR1,045 million in Q2 FY '26, up by 9.9% year-on-year. EBITDA stood at INR408 million in Q2 FY '27 as compared to INR369 million in Q2 FY '26, up by 10.5% year-on-year. EBITDA margin for the quarter stood at 35.5%. A key milestone during Q2 was the commencement of revenue generation from our biologics services. Looking ahead, we expect improvement in CRADS, which is Contract Research and Development Services for large molecules and clinical research during Q3 and Q4. I would request Ms. Harita Vasireddi, Managing Director of Vimta Labs Limited to provide you with the update for the quarter and half year ended 30th September '26. Open the document at this passage
Showing 1–4 of 4 documents